Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Nasdaq-listed Chinese biopharmaceutical firm BeiGene has bagged $175m from a follow-on public offering of American Depositary Shares (ADSs). -
Gecina, the French real estate investment trust, has raised €1bn after its M&A-driven rights issue was nearly three times covered.
-
Despite the summer lull, large deals are still going through in EMEA equity capital markets, including one of the year’s larger European acquisition financings, which reached a successful conclusion on Wednesday.
-
Indonesia’s Chandra Asri Petrochemical completed the placement portion of its Rph5tr ($378m) rights-plus-block combo on Monday, in a deal that benefited from the issuer’s focus on transparency.
-
Quam’s rights issue to raise HK$5.1bn ($656.2m) was under-subscribed, forcing its underwriters to cover the HK$1.2bn shortfall.
-
Chandra Asri Petrochemical’s rights-plus-block combo to raise Rph5tr ($378m) is going smoothly. The leads sent out a 'covered' message on Friday morning.
